Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The United Kingdom Semi-Solid Dosage Drugs market was valued at USD 13.73 Billion in 2025 and is expected to grow at a CAGR of 5.00%, reaching USD 22.36 Billion by 2035. The market growth is driven by the rising prevalence of chronic dermatological disorders, increasing demand for topical and transdermal drug formulations, expanding geriatric population, continuous innovation in semi-solid drug delivery technologies, and growing investments in pharmaceutical manufacturing and product development.
Key Market Trends and Insights
- By product type, creams are expected to lead the United Kingdom semi-solid dosage drugs market, accounting for approximately 42.5% of the market in the historical period.
- By route of administration, dermal is expected to dominate the market, representing approximately 88.5% of total revenue in the historical period.
- By therapeutic application, anti-inflammatory therapies are expected to lead the market with a 30.2% revenue share in the historical period.
Market Size and Forecast
- Market Size (2025): USD 13.73 Billion
- Projected Market Size (2035): USD 22.36 Billion
- CAGR (2026-2035): 5.00%
Compound Annual Growth Rate
5%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
United Kingdom Semi-Solid Dosage Drugs Market Overview
The United Kingdom semi-solid dosage drugs market comprises topical and localized pharmaceutical formulations, including creams, gels, ointments, pastes, and other semi-solid dosage forms used for the treatment of dermatological disorders, pain, infections, inflammation, wound care, and other therapeutic conditions. The market encompasses branded and generic prescription as well as over-the-counter (OTC) products administered through dermal, nasal, rectal, and other routes. The market was valued at USD 13.73 Billion in 2025, driven by the increasing prevalence of chronic skin disorders, rising demand for topical drug delivery, growing geriatric population, expanding OTC healthcare adoption, continuous innovation in semi-solid formulations, and sustained investments in pharmaceutical research, manufacturing, and advanced drug delivery technologies.
United Kingdom Semi-Solid Dosage Drugs Market Growth Analysis and Key Influencers
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
The rising prevalence of eczema, psoriasis, acne, fungal infections, and chronic wounds is driving demand for creams, gels, and ointments, supporting United Kingdom semi-solid dosage formulations market growth. |
Increasing psoriasis and eczema prevalence has boosted prescription and OTC topical cream demand across hospitals, dermatology clinics, and retail pharmacies. |
|
Market Restraints |
Stringent regulatory requirements, extensive stability and microbiological testing, manufacturing validation, lengthy approval timelines, and high development costs hinder commercialization of semi-solid pharmaceutical products, particularly complex and generic formulations. |
Manufacturers face delayed product launches because regulatory agencies require extensive stability studies, manufacturing validation, and quality documentation before approval. |
|
Market Opportunities |
Growing investment in liposomal, nanoemulsion, hydrogel, and transdermal technologies creates opportunities by improving drug delivery, bioavailability, therapeutic efficacy, and expanding topical treatment applications. |
Companies are developing nanoparticle-based topical formulations that improve skin penetration, therapeutic outcomes, patient adherence, and commercialization opportunities across indications. |
United Kingdom Semi-Solid Dosage Drugs Market Dynamics
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
United Kingdom Semi-Solid Dosage Drugs Market Growth Drivers
MHRA Approvals and NHS Dermatology Initiatives Strengthen Demand for Semi-Solid Dosage Drugs
The United Kingdom semi-solid dosage drugs market is benefiting from continued regulatory approvals and NHS efforts to improve dermatology care. According to the Medicines and Healthcare products Regulatory Agency (MHRA), 2025, ANZUPGO® (delgocitinib) cream received UK marketing authorization for adults with moderate-to-severe chronic hand eczema inadequately controlled by topical corticosteroids. Concurrently, NHS England continues prioritizing earlier management of chronic skin diseases through community-based services. From a macroeconomic perspective, expanding outpatient dermatology treatment reduces specialist referrals and hospital resource utilization while supporting investment in innovative topical pharmaceuticals.
United Kingdom Semi-Solid Dosage Drugs Market Restraints
Stringent Bioequivalence and Manufacturing Standards Increase Development Complexity
Development of semi-solid dosage drugs in the United Kingdom remains constrained by demanding regulatory requirements for formulation equivalence and product quality. As per Yashwant Pathak et al., 2025, semi-solid formulations require comprehensive physicochemical characterization, rheological assessment, stability evaluation, and in vitro performance testing to demonstrate quality and therapeutic consistency. Additionally, compliance with MHRA and UK Good Manufacturing Practice standards increases development timelines and manufacturing expenditure. These scientific and regulatory complexities continue challenging market entry for generic topical drug manufacturers.
United Kingdom Semi-Solid Dosage Drugs Market Opportunities
UK Life Sciences Investment and Domestic Manufacturing Expansion Support Future Growth
The United Kingdom continued investment in pharmaceutical manufacturing and life sciences innovation presents significant opportunities for semi-solid dosage drug development. According to the UK Government, 2025, the Life Sciences Sector Plan continues supporting advanced medicines manufacturing through targeted public-private investment and innovation funding. Additionally, Quotient Sciences, 2025 expanded UK-based integrated development and manufacturing capabilities for topical and semi-solid formulations. From a financial economics perspective, strengthening domestic manufacturing improves supply-chain resilience, enhances export competitiveness, and supports commercialization of innovative dermatological products.
United Kingdom Semi-Solid Dosage Drugs Market Trends
Innovation in Dermatology and Life Sciences Strengthens the United Kingdom Semi-Solid Dosage Drugs Market
The United Kingdom continues to strengthen its semi-solid dosage drugs market through sustained investment in dermatology research, pharmaceutical innovation, and advanced topical drug delivery technologies. According to the UK Medicines and Healthcare products Regulatory Agency (MHRA), regulatory initiatives during 2025 continued supporting timely access to innovative medicines while maintaining rigorous quality standards. The UK Life Sciences Vision and continued investment by domestic and multinational pharmaceutical companies are accelerating development of specialty dermatology products. From a macroeconomic perspective, strategic public funding, strong academic-industry collaboration, and continued investment in high-value pharmaceutical manufacturing are reinforcing long-term market resilience despite inflationary pressures and global supply chain uncertainties.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - Request a Free Sample
United Kingdom Semi-Solid Dosage Drugs Market Share
Anti-Inflammatory Therapies Continue to Lead Therapeutic Demand
Anti-inflammatory semi-solid formulations remain the largest therapeutic application in the United Kingdom due to the high prevalence of eczema, psoriasis, atopic dermatitis, and chronic inflammatory skin disorders. According to NHS England, dermatology remains one of the most frequently utilized outpatient specialties, driving continued demand for topical therapies. During 2025, the MHRA continued supporting access to innovative dermatology medicines through streamlined regulatory pathways. Increasing NHS investment in community dermatology services and specialty medicines continues supporting adoption of advanced anti-inflammatory topical formulations while encouraging sustained pharmaceutical innovation.
Leading Players in the United Kingdom Semi-Solid Dosage Drugs Market
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company with a broad portfolio spanning prescription medicines, vaccines, and specialty therapeutics. The company manufactures numerous topical and semi-solid pharmaceutical products through its branded and generic portfolios. Its extensive global manufacturing network, strong research capabilities, and established commercial presence support its leadership across United Kingdom and international pharmaceutical markets.
Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical manufacturer specializing in branded and generic medicines. The company offers a diverse range of topical and semi-solid formulations across multiple therapeutic areas while maintaining manufacturing facilities that comply with international regulatory standards. Aspen has a significant presence across emerging and developed markets through an extensive global distribution network.
Dow Development Laboratories, LLC
Dow Development Laboratories, LLC is a U.S.-based contract development and manufacturing organization (CDMO) specializing in semi-solid, liquid, and topical pharmaceutical formulations. The company provides formulation development, analytical testing, scale-up, manufacturing, and packaging services for pharmaceutical clients. Its expertise in semi-solid dosage forms makes it a recognized manufacturing partner for branded and generic drug developers.
Ashland Inc.
Ashland Inc. is a global specialty materials company supplying high-performance pharmaceutical excipients and formulation technologies. Its portfolio supports the development of creams, gels, ointments, and other semi-solid dosage forms by improving stability, viscosity, drug delivery, and patient experience. Ashland serves pharmaceutical manufacturers worldwide through technical expertise, innovation, and a broad specialty ingredients portfolio.
Other key players in the market include Piramal Pharma Limited (PPL), Aurigene Pharmaceutical Services Ltd., UPM Pharmaceuticals, Inc., Kunz Therapeutics Ltd., Sofpromed Clinical Research, LLC and Recipharm AB.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
United Kingdom Semi-Solid Dosage Drugs Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Creams
- Gels
- Ointments
- Pastes
- Others
The United Kingdom semi-solid dosage drugs market is segmented by product type based on formulation characteristics and clinical applications. Creams account for the largest share owing to their versatility, patient acceptability, and extensive use in dermatological and anti-inflammatory therapies, while gels, ointments, pastes, and other formulations address diverse therapeutic and formulation-specific requirements.
Market Breakup by Route of Administration
- Dermal
- Nasal
- Rectal
- Others
The market is categorized by route of administration according to the intended site of drug delivery. Dermal administration dominates due to its broad use in topical treatment of skin disorders and localized pain, whereas nasal, rectal, and other administration routes serve specialized therapeutic indications requiring localized or systemic drug absorption.
Market Breakup by Therapeutic Application
- Anti-Infective
- Anti-Inflammatory
- Pain Relief
- Acne Treatment
- Wound Care & Skin Repair
- Others
The market is segmented by therapeutic application based on disease indication and treatment purpose. Anti-inflammatory therapies represent the leading segment, supported by the high prevalence of inflammatory skin conditions, followed by anti-infective, pain relief, acne treatment, wound care and skin repair, and other specialized therapeutic applications.
Market Breakup by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Distribution channels are classified according to the point of dispensing and patient access. Retail pharmacies constitute the largest segment due to their extensive geographic presence, high prescription volumes, and accessibility, while hospital pharmacies support inpatient care and online pharmacies continue to expand through increasing adoption of digital healthcare services.
Key Questions Answered in the United Kingdom Semi-Solid Dosage Drugs Market Report
- What was the United Kingdom semi-solid dosage drugs market value in 2025?
- What is the United Kingdom semi-solid dosage drugs market forecast outlook for 2026-2035?
- What are the major factors aiding the United Kingdom semi-solid dosage drugs market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major United Kingdom semi-solid dosage drugs market trends?
- Which product type is expected to dominate the market segment?
- Which route of administration is projected to lead the market segment?
- Which therapeutic application is anticipated to drive the market segment?
- Which distribution channel is likely to dominate the market segment?
- Who are the key players involved in the United Kingdom semi-solid dosage drugs market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Route of Administration |
|
| Breakup by Therapeutic Application |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
